// App-Quantinova.ai

271 : Incidence and Risk Factors for Venous Thrombosis in Human Immunodeficiency Virus (HIV) Infection, Data from the Dutch Athena Cohort Study

Researchers

Presenter

  • James Francis Borjas-Howard

Principal Investigators

  • Casper Rokx

  • Colette Smit

  • Ferdinand Wit

  • Elise Pieterman

  • Karina Meijer

  • Bart Rijnders

  • Wouter Bierman

  • Vladimir Tichelaar

Medical Centers

  • Department of Pathology, University of Groningen, University Medical Center Groningen,, Groningen, Netherlands

  • Division of Hemostasis and Thrombosis, Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

  • Dutch Foundation of HIV Monitoring, Amsterdam, Netherlands

  • Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), University of Tromso - the Arctic University of Norway, Tromso, Norway

  • Division of Hemostasis and Thrombosis, Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

  • Dutch Foundation of HIV Monitoring, University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands

  • Department of Internal Medicine, Infectious Diseases Service,, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

  • Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands

Locations

  • Norway

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim